Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ulrike Schäkel
Observed names:
Schäkel, Ulrike,
U Schäkel,
U. Schaekel,
U. Schakel,
U. Schäkel,
Ulrike Schaekel,
Ulrike Schäkel
show all 7
Institution:
University Hospital Heidelberg
Observed institutions:
Philipps University of Marburg,
Heidelberg University,
University Hospital Heidelberg,
Nuremberg Hospital,
National Center for Tumor Diseases,
University Hospital Carl Gustav Carus,
Technische Universität Dresden
show all 7
OpenAlex ID:
A5043264175
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
2002
·
Christian Thiede
, Christine Steudel
, et al.
·
Blood
·
1,719
PDF
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
2002
·
Thomas Illmer
, Ulrich S Schuler
, et al.
·
PubMed
·
248
The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia
2009
·
H Seifert
, B Mohr
, et al.
·
Leukemia
·
157
Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia
2003
·
Christine Steudel
, Martin Wermke
, et al.
·
Genes Chromosomes and Cancer
·
156
MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients
2007
·
Hannes Wandt
, Ulrike Schäkel
, et al.
·
Blood
·
73
Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome
2000
·
B Mohr
, M Bornhäuser
, et al.
·
Leukemia
·
67
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
2022
·
Claudia M. Denkinger
, Maike Janssen
, et al.
·
Nature Cancer
·
62
PDF
Cytokine‐Driven Differentiation of Blasts from Patients with Acute Myelogenous and Lymphoblastic Leukemia into Dendritic Cells
2000
·
T. Köhler
, R. Plettig
, et al.
·
Stem Cells
·
59
Mutations in ras proto‐oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia
2001
·
M. Schaich
, M. Ritter
, et al.
·
British Journal of Haematology
·
55
PDF
Immunophenotyping is an independent factor for risk stratification in AML
2003
·
R. Repp
, U. Schaekel
, et al.
·
Cytometry Part B Clinical Cytometry
·
54
Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation
1997
·
Markus Ritter
, Christian Thiede
, et al.
·
British Journal of Haematology
·
50
Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
2008
·
F. P. Kroschinsky
, U. Schakel
, et al.
·
Haematologica
·
44
PDF
HLA‐DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia
2009
·
Uta Oelschlaegel
, Brigitte Mohr
, et al.
·
Cytometry Part B Clinical Cytometry
·
42
PDF
The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
2001
·
M Schaich
, T Illmer
, et al.
·
PubMed
·
35
Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.
2002
·
Markus Schaich
, Thomas Illmer
, et al.
·
PubMed
·
26
Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: data from a multicenter cohort study
2020
·
Waldemar Siemens
, Stefan S. Schönsteiner
, et al.
·
Supportive Care in Cancer
·
23
PDF
Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia
2001
·
U Platzbecker
, C Thiede
, et al.
·
Bone Marrow Transplantation
·
18
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
2020
·
Maike Janssen
, Ulrike Schäkel
, et al.
·
Trials
·
15
PDF
Leukozytose
2007
·
F. Kroschinsky
, U. Schäkel
, et al.
·
Der Internist
·
7
Association with the single-nucleotide polymorphism (Glu785Lys) of the granulocyte colony-stimulating factor receptor with myelodysplastic syndromes and acute myeloid leukemia with multlineage dysplasia
2006
·
U Platzbecker
, U Germing
, et al.
·
Leukemia
·
4
S282: a Randomized Controlled Clinical Trial Demonstrates That Plasma From Convalescent and Vaccinated Donors Improves Outcome of Covid-19 in Patients With Hematological Disease, Cancer or Immunosuppression
2022
·
C. Müller-Tidow
, M. Janssen
, et al.
·
HemaSphere
·
2
Mutations of the SHP-2 Proteine Tyrosine Phosphatase in Adult Patients with Acute Myeloid Leukemia.
2004
·
Christian Thiede
, Christine Steudel
, et al.
·
Blood
·
2
Rapid Risk-Profiling Including Fast Donor Search within a Multi-Center Trial Allows for Early Allogeneic Stem Cell Transplantation during Aplasia in Patients with High-Risk Acute Myeloid Leukemia.
2004
·
Markus Andreas Schaich
, Monika Fuessel
, et al.
·
Blood
·
2
Cup-Like AML - New Disease or Morphological Phenomenon?.
2006
·
Frank P. Kroschinsky
, Ulrike Schaekel
, et al.
·
Blood
·
1
1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial
2022
·
Claudia M Denkinger
, Maike Janssen
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
37
Citation count:
2,921
H-index:
17
I10-index:
18
Year
Topic
Type
